In this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week's podcast, Neurology Today's editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson's in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer's.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
137 Listeners
322 Listeners
498 Listeners
296 Listeners
49 Listeners
13 Listeners
191 Listeners
93 Listeners
514 Listeners
136 Listeners
368 Listeners
190 Listeners
374 Listeners
6 Listeners
83 Listeners